Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 I am postmenopausal, and stopped the Premprin I was on when the study reported what it had found. Now, my GYN says that I shouldn't start the estrogen again, in any form. Roni Dusty <dusty@...> wrote: I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. There are some excellent books on hormones by Dr. Vliet. Before you take the word of anyone on this list (mine included) avail yourself of some of this reading material. There are also studies posted on MEDSCAPE (you join, but no fee) and other medical sites. Dusty Re: Re: Anyone with weight gain have Liposuction? iodine and progesterone. seriously, iodine/iodide works miracles ( that's why we are warned not to take it) gracia Hi Sam, Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my boobs hurt like 2 weeks before my period, and this just started since taking Armour, 6 months. Do you know what to do to stop that?? Thanks!! Sam <k9gangopenaccess (DOT) <mailto:k9gang%40openaccess.org> org> wrote: It's not just that I have lost 2 parts of my endocrine system and started with a clean slate. There was damage done and severe iodine deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS damage from the RAI and stuff like that. I was sort of ok just without ovaries/uterus, but the bottom dropped out when my healthy thyroid was ablated. Yea, I wish it was just " starting with a clean slate " ...it would have been way easier to climb out of that pit of doom I was lolling in for so long. :-O Sam :-D > > > > I don't think it's so much what you're dosing for, as it is " how " . > You > > could dose hypothyroidism by using cocaine and probably feel pretty > > good... For a while. In your case you're using a product that treats > > the underlying disease, so it works. At least for you. So you > aren't > > JUST treating symptoms; you're addressing the real problem. > > > > Note I said it has it's limitations; I didn't say it wouldn't work. > > > > > > > > > > > --------------------------------- > Be a better friend, newshound, and know-it-all with Mobile. Try it now. > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 , I have the same problem along with being big in that area and my ob/gyn suggested evening primrose with vitamin E and it works great for me.-it even worked on the cramping,headaches and bloating.. -- In hypothyroidism , " Dusty " <dusty@...> wrote: > > I would advise against progesterone if you are a post menopausal woman. > Progsterone/Progestins are the reason the Women's Health Iniative on > combined estrogens and progestins was cancelled, due to its contributing to > breast cancer increases. The estrogen alone study continued because it did > not increase the risk of breast cancer. > > There are some excellent books on hormones by Dr. Vliet. Before > you take the word of anyone on this list (mine included) avail yourself of > some of this reading material. There are also studies posted on MEDSCAPE > (you join, but no fee) and other medical sites. > > Dusty > > > > Re: Re: Anyone with weight gain have Liposuction? > > > > > iodine and progesterone. > seriously, iodine/iodide works miracles ( that's why we are warned not to > take it) > gracia > > Hi Sam, > Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my > boobs hurt like 2 weeks before my period, and this just started since taking > Armour, 6 months. Do you know what to do to stop that?? > Thanks!! > > > Sam <k9gangopenaccess (DOT) <mailto:k9gang%40openaccess.org> org> wrote: > It's not just that I have lost 2 parts of my endocrine system and > started with a clean slate. There was damage done and severe iodine > deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS > damage from the RAI and stuff like that. I was sort of ok just > without ovaries/uterus, but the bottom dropped out when my healthy > thyroid was ablated. > > Yea, I wish it was just " starting with a clean slate " ...it would have > been way easier to climb out of that pit of doom I was lolling in for > so long. :-O > > Sam :-D > > > > > > > > I don't think it's so much what you're dosing for, as it > is " how " . > > You > > > could dose hypothyroidism by using cocaine and probably feel > pretty > > > good... For a while. In your case you're using a product that > treats > > > the underlying disease, so it works. At least for you. So you > > aren't > > > JUST treating symptoms; you're addressing the real problem. > > > > > > Note I said it has it's limitations; I didn't say it wouldn't > work. > > > > > > > > > > > > > > > > > > > > --------------------------------- > > Be a better friend, newshound, and know-it-all with Mobile. > Try it now. > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 Hi Joy, Thank you for the email. How much of each do you take? How long did it take before you noticed a difference? ) Thanks!! joy <jwalker8869@...> wrote: , I have the same problem along with being big in that area and my ob/gyn suggested evening primrose with vitamin E and it works great for me.-it even worked on the cramping,headaches and bloating.. -- In hypothyroidism , " Dusty " <dusty@...> wrote: > > I would advise against progesterone if you are a post menopausal woman. > Progsterone/Progestins are the reason the Women's Health Iniative on > combined estrogens and progestins was cancelled, due to its contributing to > breast cancer increases. The estrogen alone study continued because it did > not increase the risk of breast cancer. > > There are some excellent books on hormones by Dr. Vliet. Before > you take the word of anyone on this list (mine included) avail yourself of > some of this reading material. There are also studies posted on MEDSCAPE > (you join, but no fee) and other medical sites. > > Dusty > > > > Re: Re: Anyone with weight gain have Liposuction? > > > > > iodine and progesterone. > seriously, iodine/iodide works miracles ( that's why we are warned not to > take it) > gracia > > Hi Sam, > Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my > boobs hurt like 2 weeks before my period, and this just started since taking > Armour, 6 months. Do you know what to do to stop that?? > Thanks!! > > > Sam <k9gangopenaccess (DOT) <mailto:k9gang%40openaccess.org> org> wrote: > It's not just that I have lost 2 parts of my endocrine system and > started with a clean slate. There was damage done and severe iodine > deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS > damage from the RAI and stuff like that. I was sort of ok just > without ovaries/uterus, but the bottom dropped out when my healthy > thyroid was ablated. > > Yea, I wish it was just " starting with a clean slate " ...it would have > been way easier to climb out of that pit of doom I was lolling in for > so long. :-O > > Sam :-D > > > > > > > > I don't think it's so much what you're dosing for, as it > is " how " . > > You > > > could dose hypothyroidism by using cocaine and probably feel > pretty > > > good... For a while. In your case you're using a product that > treats > > > the underlying disease, so it works. At least for you. So you > > aren't > > > JUST treating symptoms; you're addressing the real problem. > > > > > > Note I said it has it's limitations; I didn't say it wouldn't > work. > > > > > > > > > > > > > > > > > > > > --------------------------------- > > Be a better friend, newshound, and know-it-all with Mobile. > Try it now. > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 Hi Dusty, Thanks so much for the info!! I get scared with any hormones, to tell you the truth!! I just wish that I could figure all of this out. I will definately look into these references. I am in my mid 30's, but still am afraid of HRT. I have heard the same things about breast cancer. ) Thank you again, Dusty <dusty@...> wrote: I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. There are some excellent books on hormones by Dr. Vliet. Before you take the word of anyone on this list (mine included) avail yourself of some of this reading material. There are also studies posted on MEDSCAPE (you join, but no fee) and other medical sites. Dusty Re: Re: Anyone with weight gain have Liposuction? iodine and progesterone. seriously, iodine/iodide works miracles ( that's why we are warned not to take it) gracia Hi Sam, Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my boobs hurt like 2 weeks before my period, and this just started since taking Armour, 6 months. Do you know what to do to stop that?? Thanks!! Sam <k9gangopenaccess (DOT) <mailto:k9gang%40openaccess.org> org> wrote: It's not just that I have lost 2 parts of my endocrine system and started with a clean slate. There was damage done and severe iodine deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS damage from the RAI and stuff like that. I was sort of ok just without ovaries/uterus, but the bottom dropped out when my healthy thyroid was ablated. Yea, I wish it was just " starting with a clean slate " ...it would have been way easier to climb out of that pit of doom I was lolling in for so long. :-O Sam :-D > > > > I don't think it's so much what you're dosing for, as it is " how " . > You > > could dose hypothyroidism by using cocaine and probably feel pretty > > good... For a while. In your case you're using a product that treats > > the underlying disease, so it works. At least for you. So you > aren't > > JUST treating symptoms; you're addressing the real problem. > > > > Note I said it has it's limitations; I didn't say it wouldn't work. > > > > > > > > > > > --------------------------------- > Be a better friend, newshound, and know-it-all with Mobile. Try it now. > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm\ #1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envir\ ocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> ________________________________________________________________________________\ _________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi.org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi.org/findings/ht/eplusp_bc.php<http://www.whi.org/findings/ht/eplu\ sp_bc.php> ________________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi.org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi.org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi.org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi.org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi.org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi.org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi.org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi.org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi.org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi.org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi.org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi.org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi.org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi.org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi.org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi.org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi.org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi.org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi.org/faq/faq_bc.php<http://www.whi.org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/> Share experiences with other parents. . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 Correct in that synthetic sex hormones are bad bad bad news. WIH study only looked at synthetic sex hormones, not at any of the bio-identicals. So far the bio-identicals have proven to be safe as long as they are not abused as in the wiley protocol which recommended huge overdosages of progesterone and estradiol. Sam > > I would advise against progesterone if you are a post menopausal woman. > Progsterone/Progestins are the reason the Women's Health Iniative on > combined estrogens and progestins was cancelled, due to its contributing to > breast cancer increases. The estrogen alone study continued because it did > not increase the risk of breast cancer. > > There are some excellent books on hormones by Dr. Vliet. Before > you take the word of anyone on this list (mine included) avail yourself of > some of this reading material. There are also studies posted on MEDSCAPE > (you join, but no fee) and other medical sites. > > Dusty Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 I don't think you are being well served by a gyno who doesn't know what estrogen does, and how it affects fibro. There are good books on hormones like Hormone Solutions by Thierry Hertoghe MD. Gracia I am postmenopausal, and stopped the Premprin I was on when the study reported what it had found. Now, my GYN says that I shouldn't start the estrogen again, in any form. Roni Recent Activity a.. 11New Members Visit Your Group Health Fit for Life Getting fit is now easier than ever. Sell Online Start selling with our award-winning e-commerce tools. Latest product news Join Mod. Central stay connected. . ------------------------------------------------------------------------------ No virus found in this incoming message. Checked by AVG Free Edition. Version: 7.5.516 / Virus Database: 269.19.2/1223 - Release Date: 1/13/2008 8:23 PM Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 this study used PROGESTINS which we know are dangerous, not progesterone. Gracia actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm\ #1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envir\ ocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> __________________________________________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi.org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi.org/findings/ht/eplusp_bc.php<http://www.whi.org/findings/ht/eplu\ sp_bc.php> __________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi.org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi.org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi.org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi.org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi.org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi.org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi.org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi.org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi.org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi.org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi.org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi.org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi.org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi.org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi.org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi.org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi.org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi.org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi.org/faq/faq_bc.php<http://www.whi.org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/> Share experiences with other parents. . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 My daughter had that and she told me that she felt better when she didn't eat bread. Dauphine999 and Irwin <familyirwin@...> wrote: Hi Joy, Thank you for the email. How much of each do you take? How long did it take before you noticed a difference? ) Thanks!! joy <jwalker8869@...> wrote: , I have the same problem along with being big in that area and my ob/gyn suggested evening primrose with vitamin E and it works great for me.-it even worked on the cramping,headaches and bloating.. -- In hypothyroidism , " Dusty " <dusty@...> wrote: > > I would advise against progesterone if you are a post menopausal woman. > Progsterone/Progestins are the reason the Women's Health Iniative on > combined estrogens and progestins was cancelled, due to its contributing to > breast cancer increases. The estrogen alone study continued because it did > not increase the risk of breast cancer. > > There are some excellent books on hormones by Dr. Vliet. Before > you take the word of anyone on this list (mine included) avail yourself of > some of this reading material. There are also studies posted on MEDSCAPE > (you join, but no fee) and other medical sites. > > Dusty > > > > Re: Re: Anyone with weight gain have Liposuction? > > > > > iodine and progesterone. > seriously, iodine/iodide works miracles ( that's why we are warned not to > take it) > gracia > > Hi Sam, > Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my > boobs hurt like 2 weeks before my period, and this just started since taking > Armour, 6 months. Do you know what to do to stop that?? > Thanks!! > > > Sam <k9gangopenaccess (DOT) <mailto:k9gang%40openaccess.org> org> wrote: > It's not just that I have lost 2 parts of my endocrine system and > started with a clean slate. There was damage done and severe iodine > deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS > damage from the RAI and stuff like that. I was sort of ok just > without ovaries/uterus, but the bottom dropped out when my healthy > thyroid was ablated. > > Yea, I wish it was just " starting with a clean slate " ...it would have > been way easier to climb out of that pit of doom I was lolling in for > so long. :-O > > Sam :-D > > > > > > > > I don't think it's so much what you're dosing for, as it > is " how " . > > You > > > could dose hypothyroidism by using cocaine and probably feel > pretty > > > good... For a while. In your case you're using a product that > treats > > > the underlying disease, so it works. At least for you. So you > > aren't > > > JUST treating symptoms; you're addressing the real problem. > > > > > > Note I said it has it's limitations; I didn't say it wouldn't > work. > > > > > > > > > > > > > > > > > > > > --------------------------------- > > Be a better friend, newshound, and know-it-all with Mobile. > Try it now. > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 Thanks Nancie, I will look into this as well. I know I have read that progesterone cream helps a lot with correcting underlying estrogen dominance, but I get fearful with adding hormones (because I just don't know how to weed through all of the stuff.) Thanks again, Nancie Barnett <deifspirit@...> wrote: actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm\ #1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envir\ ocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> __________________________________________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi.org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi.org/findings/ht/eplusp_bc.php<http://www.whi.org/findings/ht/eplu\ sp_bc.php> __________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi.org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi.org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi.org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi.org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi.org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi.org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi.org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi.org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi.org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi.org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi.org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi.org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi.org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi.org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi.org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi.org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi.org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi.org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi.org/faq/faq_bc.php<http://www.whi.org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/> Share experiences with other parents. .. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 michelle, just caught your message while reading this post.. the brand I use is Nature's Resource Evening Primrose with Vitamin E, 500 mg extract softgels. I take the max amount..I usually shy away from pushing products but it worked so well for me I just had to tell you.. I also stay clear of caffeine the two before and during.. I'm suppose to stay clear 24/7 but when you are HypO you want your caffeine. take care.. joy Re: Re: Anyone with weight gain have Liposuction? > > > > > iodine and progesterone. > seriously, iodine/iodide works miracles ( that's why we are warned not to > take it) > gracia > > Hi Sam, > Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my > boobs hurt like 2 weeks before my period, and this just started since taking > Armour, 6 months. Do you know what to do to stop that?? > Thanks!! > > > Sam <k9gangopenaccess (DOT) <mailto:k9gang% 40openaccess. org> org> wrote: > It's not just that I have lost 2 parts of my endocrine system and > started with a clean slate. There was damage done and severe iodine > deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS > damage from the RAI and stuff like that. I was sort of ok just > without ovaries/uterus, but the bottom dropped out when my healthy > thyroid was ablated. > > Yea, I wish it was just " starting with a clean slate " ...it would have > been way easier to climb out of that pit of doom I was lolling in for > so long. :-O > > Sam :-D > > > > > > > > I don't think it's so much what you're dosing for, as it > is " how " . > > You > > > could dose hypothyroidism by using cocaine and probably feel > pretty > > > good... For a while. In your case you're using a product that > treats > > > the underlying disease, so it works. At least for you. So you > > aren't > > > JUST treating symptoms; you're addressing the real problem. > > > > > > Note I said it has it's limitations; I didn't say it wouldn't > work. > > > > > > > > > > > > > > > > > > > > ------------ --------- --------- --- > > Be a better friend, newshound, and know-it-all with Mobile. > Try it now. > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 If there is prementrual swelling of breast tissue, you might want to try 20 mgs of furosemide with a 99mgs potassium pill for the few days before your period. You'll need a prescription. I know there are natural water pills, but I don't know how effective they are, honestly. Roni and Irwin <familyirwin@...> wrote: Thanks Nancie, I will look into this as well. I know I have read that progesterone cream helps a lot with correcting underlying estrogen dominance, but I get fearful with adding hormones (because I just don't know how to weed through all of the stuff.) Thanks again, Nancie Barnett <deifspirit@...> wrote: actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm\ #1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envir\ ocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> __________________________________________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi.org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi.org/findings/ht/eplusp_bc.php<http://www.whi.org/findings/ht/eplu\ sp_bc.php> __________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi.org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi.org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi.org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi.org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi.org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi.org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi.org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi.org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi.org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi.org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi.org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi.org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi.org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi.org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi.org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi.org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi.org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi.org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi.org/faq/faq_bc.php<http://www.whi.org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/> Share experiences with other parents. .. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 Gracia - This is a dangerous statement. We do NOT know whether or not progesterone is dangerous - as it has never been studied. There is absolutely no proof of your claim. Re: /Painful breasts this study used PROGESTINS which we know are dangerous, not progesterone. Gracia actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer <http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> ..cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer <http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> ..cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer <http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> ..cornell.edu/Factsheet/general/fs40.hormones.cfm#1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer <http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> ..cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envirocancer <http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> ..cornell.edu/Factsheet/general/fs40.hormones.cfm> __________________________________________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi. <http://www.whi.org/faq/faq_bc.php> org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama. <http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi. <http://www.whi.org/findings/ht/eplusp_bc.php> org/findings/ht/eplusp_bc.php<http://www.whi. <http://www.whi.org/findings/ht/eplusp_bc.php> org/findings/ht/eplusp_bc.php> __________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#1> org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#2> org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#3> org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#4> org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#5> org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#6> org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#7> org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#8> org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#9> org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#10> org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#11> org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#12> org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#13> org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi. <http://www.whi.org/faq/faq_bc.php#14> org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#15> org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#16> org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi. <http://www.whi.org/faq/faq_bc.php#17> org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi. <http://www.whi.org/updates/update_hrt2004.php> org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi. <http://www.whi.org/faq/faq_bc.php> org/faq/faq_bc.php<http://www.whi. <http://www.whi.org/faq/faq_bc.php> org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<http://groups. <hypothyroidism/members;_ylc=X3oDMTJlcGdydnA2B F9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDd m1icnMEc3RpbWUDMTIwMDM1ODYyOA--> /group/hypothyroidism/members;_ylc=X3oDMTJlcGdydnA2BF9TAzk3MzU5NzE0 BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm1icnMEc3RpbWUD MTIwMDM1ODYyOA--> Visit Your Group <http://groups. <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3M zU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzd GltZQMxMjAwMzU4NjI4> /group/hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5NzE0BGdycElk AzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxMjAwMzU4 NjI4> Health Looking for Love?<http://us.ard. <http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D= grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l /*http://health./> /SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D=grphealth/S=170 9251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*http://health ../> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard. <http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/ *http://us.rd./evt=44092/*http://smallbusiness./webhosting /sitebuilding.php> /SIG=12m5h54ok/M=493064.12016255.124456628674578/D=grphealth/S=1709 251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*http://us.rd.y ahoo.com/evt=44092/*http://smallbusiness./webhosting/sitebuilding.p hp> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard. <http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/ *http://advision.webevents./parenting/> /SIG=12m63gngl/M=493064.12016283.124456878674578/D=grphealth/S=1709 251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*http://advisio n.webevents./parenting/> Share experiences with other parents. .. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 gracia- if you read the study below- PROGESTERONE IS CITED IN THE STUDY. PROGESTINS ARE AL LAYMAN'S TERM FOR PROGESTERONE. Please, do not tell me what the study was about BECAUSE UCLA WAS INVOLVED in the study when I was in GRADUATE SCHOOL THERE. many of the researches who worked with the study were from UCLA. Several of my professors in women's health were involved in the study. /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--<hypothyroidism/memb\ ers;_ylc=X3oDMTJlcGdydnA2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTE\ wODIEc2VjA3Z0bARzbGsDdm1icnMEc3RpbWUDMTIwMDM1ODYyOA-->> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4<hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF\ 9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocA\ RzdGltZQMxMjAwMzU4NjI4>> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.\ 12445695.9706571/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=\ 0/SIG=10q26t77l/*http://health./>> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php<http://us.ard./SIG=12m5h54ok/M=493064.12016255.12445662867457\ 8/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb\ /*http://us.rd./evt=44092/*http://smallbusiness./webhosting/si\ tebuilding.php>> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/<http://us.ard./SIG=12m63gng\ l/M=493064.12016283.124456878674578/D=grphealth/S=1709251082:NC/Y=/EXP=1200\ 365828/A=5045819/R=0/SIG=11gsqr691/*http://advision.webevents./parentin\ g/>> Share experiences with other parents. . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 Incorrect Sam. There is no such proof because the studies haven't been done on bio's alone. How silly and irresponsible of you to make such a claim when no one actually knows how many women have come down with hormonally caused cancers while using only bio's. Dusty Re: /Painful breasts Correct in that synthetic sex hormones are bad bad bad news. WIH study only looked at synthetic sex hormones, not at any of the bio-identicals. So far the bio-identicals have proven to be safe as long as they are not abused as in the wiley protocol which recommended huge overdosages of progesterone and estradiol. Sam > > I would advise against progesterone if you are a post menopausal woman. > Progsterone/Progestins are the reason the Women's Health Iniative on > combined estrogens and progestins was cancelled, due to its contributing to > breast cancer increases. The estrogen alone study continued because it did > not increase the risk of breast cancer. > > There are some excellent books on hormones by Dr. Vliet. Before > you take the word of anyone on this list (mine included) avail yourself of > some of this reading material. There are also studies posted on MEDSCAPE > (you join, but no fee) and other medical sites. > > Dusty Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 plus PROGESTERONES ARE NOT DANGEROUS IF YOU USE THEM CORRECTLY, GRACIA. OBIVIOUSLY IF YOU OVERDOSE ON ANY NATURAL SUBSTANCE IT CAN BE DANGEROUS. THE SMART IDEA IS NOT TO. PROGESTERONE is the CHEMICAL name for PROGESTIN [ which is a class of drug ]. I do not expect you to really know that since you are a medical provider..... /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--<hypothyroidism/memb\ ers;_ylc=X3oDMTJlcGdydnA2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTE\ wODIEc2VjA3Z0bARzbGsDdm1icnMEc3RpbWUDMTIwMDM1ODYyOA-->> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4<hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF\ 9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocA\ RzdGltZQMxMjAwMzU4NjI4>> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.\ 12445695.9706571/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=\ 0/SIG=10q26t77l/*http://health./>> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php<http://us.ard./SIG=12m5h54ok/M=493064.12016255.12445662867457\ 8/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb\ /*http://us.rd./evt=44092/*http://smallbusiness./webhosting/si\ tebuilding.php>> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/<http://us.ard./SIG=12m63gng\ l/M=493064.12016283.124456878674578/D=grphealth/S=1709251082:NC/Y=/EXP=1200\ 365828/A=5045819/R=0/SIG=11gsqr691/*http://advision.webevents./parentin\ g/>> Share experiences with other parents. . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 So far, the bioidenticals are proving to be SAFE according to the doctors that have been prescribing them and the people that are taking them. ASK THEM yourself. My 11+ grains of Armour and my BHRT are currently being presribed by real live medical care professionals, so what is your problem! > > Incorrect Sam. There is no such proof because the studies haven't been done > on bio's alone. How silly and irresponsible of you to make such a claim > when no one actually knows how many women have come down with hormonally > caused cancers while using only bio's. > > Dusty > > Re: /Painful breasts > > > > Correct in that synthetic sex hormones are bad bad bad news. > WIH study only looked at synthetic sex hormones, not at any of the > bio-identicals. So far the bio-identicals have proven to be safe as > long as they are not abused as in the wiley protocol which > recommended huge overdosages of progesterone and estradiol. > > Sam Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 17, 2008 Report Share Posted January 17, 2008 Gracia, Cortef is cortisone Progestin is progesterone It's simple. Whatever the name they give to it the drug is the same. Roni Nancie Barnett <deifspirit@...> wrote: gracia- if you read the study below- PROGESTERONE IS CITED IN THE STUDY. PROGESTINS ARE AL LAYMAN'S TERM FOR PROGESTERONE. Please, do not tell me what the study was about BECAUSE UCLA WAS INVOLVED in the study when I was in GRADUATE SCHOOL THERE. many of the researches who worked with the study were from UCLA. Several of my professors in women's health were involved in the study. /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--<hypothyroidism/memb\ ers;_ylc=X3oDMTJlcGdydnA2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTE\ wODIEc2VjA3Z0bARzbGsDdm1icnMEc3RpbWUDMTIwMDM1ODYyOA-->> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4<hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF\ 9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocA\ RzdGltZQMxMjAwMzU4NjI4>> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.\ 12445695.9706571/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=\ 0/SIG=10q26t77l/*http://health./>> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php<http://us.ard./SIG=12m5h54ok/M=493064.12016255.12445662867457\ 8/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb\ /*http://us.rd./evt=44092/*http://smallbusiness./webhosting/si\ tebuilding.php>> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/<http://us.ard./SIG=12m63gng\ l/M=493064.12016283.124456878674578/D=grphealth/S=1709251082:NC/Y=/EXP=1200\ 365828/A=5045819/R=0/SIG=11gsqr691/*http://advision.webevents./parentin\ g/>> Share experiences with other parents. .. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 17, 2008 Report Share Posted January 17, 2008 Thanks Joy! I will check this out. :0) Joy <jwalker8869@...> wrote: michelle, just caught your message while reading this post.. the brand I use is Nature's Resource Evening Primrose with Vitamin E, 500 mg extract softgels. I take the max amount..I usually shy away from pushing products but it worked so well for me I just had to tell you.. I also stay clear of caffeine the two before and during.. I'm suppose to stay clear 24/7 but when you are HypO you want your caffeine. take care.. joy Re: Re: Anyone with weight gain have Liposuction? > > > > > iodine and progesterone. > seriously, iodine/iodide works miracles ( that's why we are warned not to > take it) > gracia > > Hi Sam, > Since you mentioned it, about Fibrocystic Breast Disease: I noticed that my > boobs hurt like 2 weeks before my period, and this just started since taking > Armour, 6 months. Do you know what to do to stop that?? > Thanks!! > > > Sam <k9gangopenaccess (DOT) <mailto:k9gang% 40openaccess. org> org> wrote: > It's not just that I have lost 2 parts of my endocrine system and > started with a clean slate. There was damage done and severe iodine > deficiency - fibrocystic breast disease, osteoporosis, DNA and NIS > damage from the RAI and stuff like that. I was sort of ok just > without ovaries/uterus, but the bottom dropped out when my healthy > thyroid was ablated. > > Yea, I wish it was just " starting with a clean slate " ...it would have > been way easier to climb out of that pit of doom I was lolling in for > so long. :-O > > Sam :-D > > > > > > > > I don't think it's so much what you're dosing for, as it > is " how " . > > You > > > could dose hypothyroidism by using cocaine and probably feel > pretty > > > good... For a while. In your case you're using a product that > treats > > > the underlying disease, so it works. At least for you. So you > > aren't > > > JUST treating symptoms; you're addressing the real problem. > > > > > > Note I said it has it's limitations; I didn't say it wouldn't > work. > > > > > > > > > > > > > > > > > > > > ------------ --------- --------- --- > > Be a better friend, newshound, and know-it-all with Mobile. > Try it now. > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 17, 2008 Report Share Posted January 17, 2008 Thanks Roni, You said something very interesting...I wonder if I am gaining weight because of water retention. Would that indicate kidney issues?? Thanks!! Roni Molin <matchermaam@...> wrote: If there is prementrual swelling of breast tissue, you might want to try 20 mgs of furosemide with a 99mgs potassium pill for the few days before your period. You'll need a prescription. I know there are natural water pills, but I don't know how effective they are, honestly. Roni and Irwin <familyirwin@...> wrote: Thanks Nancie, I will look into this as well. I know I have read that progesterone cream helps a lot with correcting underlying estrogen dominance, but I get fearful with adding hormones (because I just don't know how to weed through all of the stuff.) Thanks again, Nancie Barnett <deifspirit@...> wrote: actually that is not entirely correct. the study was terminated early because the Combined therapy of both estrogen and progesterone was seen to increase the risk of breast cancer. we do NOT have any info on whether progesterone ALONe causes breast cancer- because there has NEVER been a study targeting it that. nancie here is the first source: Does postmenopausal hormone treatment increase the risk of breast cancer? Women who use postmenopausal hormone treatment<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormonescfm#1> have a higher risk for breast cancer compared with women who do not use hormone treatment. In the past, hormone treatment used estrogen<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm#1> alone and the effects of this treatment have been studied more extensively. These early studies saw breast cancer risk increase the longer the length of the estrogen treatment. Breast cancer risk among women who used hormone treatment, increased about 2% for each year of use compared to women who did not use hormones. When hormone treatment is stopped, risk falls to previous levels over a period of five years. Today, most women who receive postmenopausal hormone treatment use estrogen combined with progesterone<http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm\ #1>. A number of recent studies indicate a higher risk of breast cancer is associated with this form of hormone treatment. These studies found that estrogen with progesterone treatment increased breast cancer risk by 6% to 8% for each year of use. Confirming these results, a large clinical trial examining estrogen with progesterone treatment in healthy women, the Women's Health Initiative, was recently ended prematurely because of an association of excessive breast cancer risk with this treatment. Trials of this type are the 'gold standard' for examining drug effects and this early termination result raises strong concern about the use of estrogen with progesterone as a beneficial treatment for healthy women after menopause. source: http://envirocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm<http://envir\ ocancer.cornell.edu/Factsheet/general/fs40.hormones.cfm> __________________________________________________________ Estrogen plus Progestin Effects on Breast Cancer and Mammograms June 2003 a.. Frequently asked questions<http://www.whi.org/faq/faq_bc.php> b.. Abstract of scientific paper in JAMA<http://jama.ama-assn.org/cgi/content/abstract/289/24/3243> Findings Summary WHI study findings on the risk of breast cancer in women taking combined estrogen plus progestin (E+P) were published in the July 2002 issue of the Journal of the American Medical Association (JAMA). The E+P study continues to be analyzed. Updated results (June 25 issue of JAMA) include data on additional breast cancer cases, their characteristics, and mammogram results for women in the study. The 2002 report showed that more women taking E+P developed breast cancer than those taking placebo (inactive) pills. This updated analysis shows that after an average of 5.6 years, 245 of the 8,506 E+P women and 185 of the 8,102 women on placebo developed breast cancer. Of the total cancers, 349 cases were invasive, a type of breast cancer with a greater chance of spreading to other parts of the body. The conclusions below are based on the invasive breast cancer group. a.. The increased risk of breast cancer due to E+P was eight additional cases of breast cancer for every 10,000 women over one year b.. Overall, there was a 24% increase in the risk for breast cancer due to E+P The breast cancers in the E+P group had similar characteristics (looked the same under a microscope) to those in the placebo group. However, the tumors in the E+P group tended to be larger and more advanced (had spread to the lymph nodes or elsewhere in the body). A more advanced stage is usually associated with poorer outcome. At this time, no direct statements can be made about the prognosis of the breast cancer found in women taking E+P until more follow-up information is collected. After even one year, quite a few more women had abnormal mammograms in the E+P group (9.4%) compared to the placebo group (5.4%); this pattern continued until the study ended. An abnormal mammogram is a breast X-ray that results in a recommendation for additional medical evaluation (most often, a shorter time between mammograms, but sometimes, a breast biopsy or other tests). Although we have known from other studies that E+P use increases the density of breast tissue on mammograms, the increase in abnormal mammograms with E+P use seen in this study is a new finding. Further WHI studies are being done to learn what happens to breast cancer rates and mammograms after E+P use is stopped. source: http://www.whi.org/findings/ht/eplusp_bc.php<http://www.whi.org/findings/ht/eplu\ sp_bc.php> __________________________________________________________ Frequently Asked Questions about Estrogen plus Progestin and Breast Cancer These questions and answers supplement the June 25, 2003 JAMA publication on E+P and breast cancer. 1.. What were the main findings from the estrogen plus progestin and breast cancer analyses?<http://www.whi.org/faq/faq_bc.php#1> 2.. What is the increased risk for women taking E+P for breast cancer?<http://www.whi.org/faq/faq_bc.php#2> 3.. What were the main findings about E+P and mammography?<http://www.whi.org/faq/faq_bc.php#3> 4.. What are the conclusions from these findings?<http://www.whi.org/faq/faq_bc.php#4> 5.. What is breast cancer?<http://www.whi.org/faq/faq_bc.php#5> 6.. What is in situ breast cancer?<http://www.whi.org/faq/faq_bc.php#6> 7.. What is invasive breast cancer?<http://www.whi.org/faq/faq_bc.php#7> 8.. What is a mammogram?<http://www.whi.org/faq/faq_bc.php#8> 9.. What is an abnormal mammogram?<http://www.whi.org/faq/faq_bc.php#9> 10.. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued?<http://www.whi.org/faq/faq_bc.php#10> 11.. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study?<http://www.whi.org/faq/faq_bc.php#11> 12.. What type of hormone treatment did women in the E+P study take?<http://www.whi.org/faq/faq_bc.php#12> 13.. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?<http://www.whi.org/faq/faq_bc.php#13> 14.. Should I discuss this information with my healthcare provider? <http://www.whi.org/faq/faq_bc.php#14> 15.. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do?<http://www.whi.org/faq/faq_bc.php#15> 16.. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past?<http://www.whi.org/faq/faq_bc.php#16> 17.. I am taking prescription hormones. What should I do?<http://www.whi.org/faq/faq_bc.php#17> 1. What were the main findings from the estrogen plus progestin and breast cancer analyses? Answer: More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group. 2. What is the increased risk for women taking E+P for breast cancer? Answer: A woman is more likely to develop breast cancer if she is taking E+P. For every 10,000 women taking estrogen plus progestin, 41 women each year will develop breast cancer as compared to 33 women per year who would develop breast cancer while taking placebo. While this difference in risk is important, the overall risk to an individual woman remains small. The breast cancer cases which developed in women taking E+P were larger and more advanced; about 25% had spread to lymph nodes or elsewhere in the body, compared to 16% of women on placebo. 3. What were the main findings about E+P and mammography? Answer: After just one year of taking E+P, a woman was much more likely to have an abnormal mammogram compared to a woman taking placebo. In the E+P group, 9.4% of women had an abnormal mammogram after one year, compared with 5.4% in the placebo group. The increased rate of abnormal mammograms continued until the study ended. A woman's chance of having an abnormal mammogram resulting from E+P use was about 1 in 25 for one year's use, and about 1 in 10 after 5½ years of use. 4. What are the conclusions from these findings? Answer: Use of E+P increases the rate of more advanced breast cancer compared with placebo and substantially increases the rate of abnormal mammograms. As a result, abnormal mammograms in women receiving menopausal hormone therapy need closer attention. The increased frequency of abnormal mammograms is a newly found negative effect of even short-term E+P use. These findings should be considered in the discussion of risks and benefits for women considering E+P use for any amount of time. 5. What is breast cancer? Answer: Breast cancer is a disease in which abnormal breast cells divide without control and can spread to other parts of the body. 6. What is in situ breast cancer? Answer: In situ is an early cancer where abnormal breast cells are confined to the ducts or lobules in the breast. There are two forms, ductal carcinoma (DCIS) and lobular carcinoma in situ (LCIS). 7. What is invasive breast cancer? Answer: Invasive breast cancer involves abnormal breast cells which have spread outside the breast duct or lobule where they began. This type of cancer accounts for 80% of breast cancer cases. When the term " breast cancer " is used, it generally means invasive breast cancer. 8. What is a mammogram? Answer: A mammogram is an X-ray of the breast. 9. What is an abnormal mammogram? Answer: An abnormal mammogram is a breast X-ray with characteristics leading the radiologist to recommend some additional testing, either another mammogram within 6 months, or occasionally other procedures. A recommendation to have a repeat mammogram seldom results in a cancer diagnosis. Some characteristics seen on a mammogram are suspicious enough to indicate that additional tests (like a biopsy) are needed. These tests are more likely to result in a cancer diagnosis. An abnormal mammogram report is not the same as an incomplete mammogram report. Quite often, a woman may be called back after a mammogram to have additional X-rays taken, have an additional non-invasive procedure performed (such as an ultrasound) or be asked to provide earlier mammograms for comparisons. These evaluations are needed to better understand the current mammogram, and by themselves do not signal an abnormal mammogram. 10. What happens to breast cancer risk and the frequency of abnormal mammograms after E+P use is discontinued? Answer: WHI researchers will be looking at these issues in future analyses, so information is not yet available. Observational studies have suggested that breast cancer risk will diminish over time. To date, no studies have looked at what effect stopping E+P use has on abnormal mammograms. There have been some studies about breast density change and menopausal hormone therapy use. Increased mammogram density has been linked to E+P use. In observational studies, mammogram density has been shown to decrease when E+P use is stopped. It remains to be seen whether abnormal mammograms will change when E+P use is stopped. 11. Was the effect of E+P on breast cancer different in women who had taken menopausal hormone therapy before entering the WHI study? Answer: There was a trend for somewhat higher risk in women in the E+P group who reported prior menopausal hormone use. Whenever researchers examine factors like this within a randomized trial, the analyses and interpretation become more complex. Prior hormone use was not randomized and so other factors associated with hormone use must be considered when analyzing this relationship. Though there appears to be some relation between prior hormone use and breast cancer, WHI researchers will be examining this in more detail to gain confidence in their interpretation. 12. What type of hormone treatment did women in the E+P study take? Answer: Women randomized (assigned by chance) to active hormones were taking one tablet containing conjugated equine estrogens (0.625 mg) and medroxyprogesterone acetate (2.5 mg) each day (PremproT). When WHI first began, this was the most commonly prescribed menopausal hormonal therapy in the United States for women with a uterus. 13. Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas? Answer: The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing Estrogen-Alone (E-Alone) study are unknown at this time. Importantly, the WHI investigators have been told that, as of May 31, 2002, no increase in breast cancer has been seen in the E-alone WHI trial. Participants in the E-Alone study are asked to continue to take their study pills and to come for their regular clinic visits. The National Heart, Lung, and Blood Institute, which oversees WHI, continues to review the study for women receiving E-Alone, and they will provide investigators and participants with any new information about the study that might affect their participation This information has been superceded by the 2004 Hormone Program Update.<http://www.whi.org/updates/update_hrt2004.php> 14. Should I discuss this information with my healthcare provider? Answer: Yes. Your healthcare provider may read the scientific paper in the June 25, 2003 issue of JAMA, or you may direct your provider to this web site. Your provider may also want to speak with your local WHI Principal Investigator about these results. 15. If I have an abnormal mammogram now, and have taken (or I still take) E+P, what should I do? Answer: Talk with your healthcare provider about your individual situation in light of the WHI results. Additional breast imaging tests may help in evaluating women with abnormal mammograms, such as a nuclear medicine test (scintimammography) or Magnetic Resonance Imaging (MRI); your mammography provider should have information about these tests. However, no approach has been evaluated for women with abnormal mammograms related to E+P use. 16. Was the effect of E+P on breast cancer different in women who had used oral contraceptives in the past? Answer: The analyses done so far do not suggest that use of oral contraceptives had any important influence on the breast cancer findings. Less than half of the women in this study had ever used oral contraceptives and the length of use was often relatively short (less than 5 years). With the small number of breast cancer cases that occurred in these women, these data do not provide a very clear answer to this question. 17. I am taking prescription hormones. What should I do? Answer: Talk with your healthcare provider about your individual risk profile and the hormones you are currently taking in light of the WHI results. source: http://www.whi.org/faq/faq_bc.php<http://www.whi.org/faq/faq_bc.php> /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/> Share experiences with other parents. .. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 17, 2008 Report Share Posted January 17, 2008 progestins are frankenstein hormones, chemically altered to be patented. progesterone cannot be patented last time I looked. progesterone is safe and bioidentical, progestin is not. I am not a medical provider, I am a health care consumer. Gracia plus PROGESTERONES ARE NOT DANGEROUS IF YOU USE THEM CORRECTLY, GRACIA. OBIVIOUSLY IF YOU OVERDOSE ON ANY NATURAL SUBSTANCE IT CAN BE DANGEROUS. THE SMART IDEA IS NOT TO. PROGESTERONE is the CHEMICAL name for PROGESTIN [ which is a class of drug ]. I do not expect you to really know that since you are a medical provider..... Recent Activity a.. 13New Members Visit Your Group Health Looking for Love? Find relationship advice and answers. Biz Resources Y! Small Business Articles, tools, forms, and more. Moderator Central An online resource for moderators of . . ------------------------------------------------------------------------------ No virus found in this incoming message. Checked by AVG Free Edition. Version: 7.5.516 / Virus Database: 269.19.6/1229 - Release Date: 1/17/2008 11:12 AM Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2008 Report Share Posted January 18, 2008 progestin's are the name of THE CLASS of hormones of which premarin, provera and depo-provera are included. PROGESTERONE is the name of the hormone that is our bodies and also the chemical structure of the hormone. when we studied progesterone in the study we used the class of drugs called progestin's because they are molecularly and CHEMICALLY identical to progesterone. AND they are the most widely used hormone replacements. the authors of the study wanted to see what these drugs would do since they ARE prescribed over 90% of the time. the study DID NOT address bio-identicals. I agree that they should do a study that included bio-identicals, so we can see if they are any risks associated with them. BUT right NOW we are in the dark as far as the long term risks with using bio-identicals in breast cancer and ovarian cancer and especially if one uses more then the recommended doses. nancie ----- Original Message ----- progestins are frankenstein hormones, chemically altered to be patented. progesterone cannot be patented last time I looked. progesterone is safe and bioidentical, progestin is not. I am not a medical provider, I am a health care consumer. Gracia . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2008 Report Share Posted January 18, 2008 grapefruit juice, cucumbers and watermelon juice are also good diuretics and asparagus also will do the trick. nancie /Painful breasts I would advise against progesterone if you are a post menopausal woman. Progsterone/Progestins are the reason the Women's Health Iniative on combined estrogens and progestins was cancelled, due to its contributing to breast cancer increases. The estrogen alone study continued because it did not increase the risk of breast cancer. Recent Activity a.. 11New Members<hypothyroidism/members;_ylc=X3oDMTJlcGdydn\ A2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdm\ 1icnMEc3RpbWUDMTIwMDM1ODYyOA--<hypothyroidism/memb\ ers;_ylc=X3oDMTJlcGdydnA2BF9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTE\ wODIEc2VjA3Z0bARzbGsDdm1icnMEc3RpbWUDMTIwMDM1ODYyOA-->> Visit Your Group <hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF9TAzk3MzU5N\ zE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocARzdGltZQMxM\ jAwMzU4NjI4<hypothyroidism;_ylc=X3oDMTJkbjdqMWk5BF\ 9TAzk3MzU5NzE0BGdycElkAzE0NTY2NARncnBzcElkAzE3MDkyNTEwODIEc2VjA3Z0bARzbGsDdmdocA\ RzdGltZQMxMjAwMzU4NjI4>> Health Looking for Love?<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.12445695.9706571/D\ =grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=0/SIG=10q26t77l/*h\ ttp://health./<http://us.ard./SIG=12m6vi1a3/M=493064.12016303.\ 12445695.9706571/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5008808/R=\ 0/SIG=10q26t77l/*http://health./>> Find relationship advice and answers. Sitebuilder Build a web site<http://us.ard./SIG=12m5h54ok/M=493064.12016255.124456628674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb/*htt\ p://us.rd./evt=44092/*http://smallbusiness./webhosting/sitebui\ lding.php<http://us.ard./SIG=12m5h54ok/M=493064.12016255.12445662867457\ 8/D=grphealth/S=1709251082:NC/Y=/EXP=1200365828/A=4025304/R=0/SIG=12uhb64pb\ /*http://us.rd./evt=44092/*http://smallbusiness./webhosting/si\ tebuilding.php>> quickly & easily with Sitebuilder. Parenting Zone<http://us.ard./SIG=12m63gngl/M=493064.12016283.124456878674578/D=g\ rphealth/S=1709251082:NC/Y=/EXP=1200365828/A=5045819/R=0/SIG=11gsqr691/*htt\ p://advision.webevents./parenting/<http://us.ard./SIG=12m63gng\ l/M=493064.12016283.124456878674578/D=grphealth/S=1709251082:NC/Y=/EXP=1200\ 365828/A=5045819/R=0/SIG=11gsqr691/*http://advision.webevents./parentin\ g/>> Share experiences with other parents. . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2008 Report Share Posted January 18, 2008 you think there should be a study to see if the hormones which are natural to our own bodies are dangerous? I wonder who would fund that one? http://www.womensinternational.com Gracia progestin's are the name of THE CLASS of hormones of which premarin, provera and depo-provera are included. PROGESTERONE is the name of the hormone that is our bodies and also the chemical structure of the hormone. when we studied progesterone in the study we used the class of drugs called progestin's because they are molecularly and CHEMICALLY identical to progesterone. AND they are the most widely used hormone replacements. the authors of the study wanted to see what these drugs would do since they ARE prescribed over 90% of the time. the study DID NOT address bio-identicals. I agree that they should do a study that included bio-identicals, so we can see if they are any risks associated with them. BUT right NOW we are in the dark as far as the long term risks with using bio-identicals in breast cancer and ovarian cancer and especially if one uses more then the recommended doses. nancie ----- Original Message ----- progestins are frankenstein hormones, chemically altered to be patented. progesterone cannot be patented last time I looked. progesterone is safe and bioidentical, progestin is not. I am not a medical provider, I am a health care consumer. Gracia . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2008 Report Share Posted January 18, 2008 I have tried that link 6 times and it won't go through nancie Re: /Painful breasts you think there should be a study to see if the hormones which are natural to our own bodies are dangerous? I wonder who would fund that one? http://www.womensinternational.com<http://www.womensinternational.com/> Gracia progestin's are the name of THE CLASS of hormones of which premarin, provera and depo-provera are included. PROGESTERONE is the name of the hormone that is our bodies and also the chemical structure of the hormone. when we studied progesterone in the study we used the class of drugs called progestin's because they are molecularly and CHEMICALLY identical to progesterone. AND they are the most widely used hormone replacements. the authors of the study wanted to see what these drugs would do since they ARE prescribed over 90% of the time. the study DID NOT address bio-identicals. I agree that they should do a study that included bio-identicals, so we can see if they are any risks associated with them. BUT right NOW we are in the dark as far as the long term risks with using bio-identicals in breast cancer and ovarian cancer and especially if one uses more then the recommended doses. nancie ----- Original Message ----- progestins are frankenstein hormones, chemically altered to be patented. progesterone cannot be patented last time I looked. progesterone is safe and bioidentical, progestin is not. I am not a medical provider, I am a health care consumer. Gracia . Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.